Xenon Pharmaceuticals XENE Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's common stock?
- Xenon Pharmaceuticals (XENE) reported common stock of $2.42B in Q1 2026.
- How has Xenon Pharmaceuticals's common stock changed year-over-year?
- Xenon Pharmaceuticals's common stock increased by 65.8% year-over-year, from $1.46B to $2.42B.
- What is the long-term trend for Xenon Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's common stock has grown at a 32.1% compound annual growth rate (CAGR), from $397.75M to $1.6B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).